Peer-reviewedCC BYFrontiers in medicine
Impact of Ayurvedic purification (Shodhana) on Mucuna pruriens for primary health care in Parkinson’s disease: phytochemical profile, bioavailability of L-DOPA, and comparative UPLC-MS/MS QTOF–Caco-2 analysis
4 affiliations
- 1Amrita School of Ayurveda, Amrita Vishwa Vidyapeetham University , ,
- 2Kasturba Medical College Manipal , ,
- 3Department of Comparative Medicine, Stanford University , , ,
- 4Amrita Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham , ,
Related
- Comparative performance of nine large language models on professional Parkinson’s disease tasks: a multidimensional benchmark study
- Comparative efficacy of gut microbiota-targeted therapies for motor and non-motor symptoms in Parkinson's disease: a systematic review and network meta-analysis
- Comparative analysis of GAN-based augmentation pipelines for Parkinson's hypokinetic dysarthria severity detection using deep learning
- Comparative effects and dose-response relationships of exercise for finger dexterity and upper-limb function in Parkinson's disease: a Bayesian network and model-based dose-response meta-analysis.
- Comparative assessment of the cytotoxicity of Nrf2-dependent signaling pathway modulators: the role of hormetic protective effect in Parkinson’s disease modeling in vitro
BibTeX
@article{salethoor2026impact,
title = {{Impact of Ayurvedic purification (Shodhana) on Mucuna pruriens for primary health care in Parkinson’s disease: phytochemical profile, bioavailability of L-DOPA, and comparative UPLC-MS/MS QTOF–Caco-2 analysis}},
author = {Sushma Naranappa Salethoor and Shyamasundaran Kulangara and Reshma N. S. and Rina Barouch Bentov and Gopi Mohan C. and Santhwana S. Nair and Rashee Pantawne and Alok Kumar Tiwari},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13669166},
note = {CC BY},
}
RIS
TY - JOUR
TI - Impact of Ayurvedic purification (Shodhana) on Mucuna pruriens for primary health care in Parkinson’s disease: phytochemical profile, bioavailability of L-DOPA, and comparative UPLC-MS/MS QTOF–Caco-2 analysis
AU - Sushma Naranappa Salethoor
AU - Shyamasundaran Kulangara
AU - Reshma N. S.
AU - Rina Barouch Bentov
AU - Gopi Mohan C.
AU - Santhwana S. Nair
AU - Rashee Pantawne
AU - Alok Kumar Tiwari
PY - 2026
DA - 2026/10/19
JO - Frontiers in medicine
UR - https://europepmc.org/article/PMC/PMC13669166
SN - 2296-858X
ER -